English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
Pediatric chronic myeloid leukemia presenting with extreme thrombocytosis and acute upper gastrointestinal haemorrhage: A case report (Zhang Y et al. J Pediatr Hematol Oncol, Oct 2021)
Pediatric chronic myeloid leukemia presenting with extreme thrombocytosis and acute upper gastrointestinal haemorrhage: A case report
Zhang Y et al. J Pediatr Hematol Oncol, October 2021
Chronic myeloid leukemia in children: immune function and vaccinations (Suttorp M et al. J Clin Med, September 2021)
Chronic myeloid leukemia in children: immune functions and vaccinations
Suttorp M et al. J Clin Med, September 2021 – open access publication
A phase 2 study of nilotinib in pediatric patients with CML: Long-term update on growth retardation and safety
A phase 2 study of nilotinib in pediatric patients with CML: Long-term update on growth retardation and safety
Hijiya N et al. Blood Adv, July 2021 (epub ahead of print) - open access publication
Discontinuation of imatinib in children with chronic myeloid leukemia: A study from the International Registry of Childhood CML (Millot F et al. Cancers(Basel), August 2021
Discontinuation of imatinib in children with chronic myeloid leukemia: A study from the International Registry of childhood CML
Millot F et al. Cancers(Basel), August 2021 – open access publication
Adolescents experienced more treatment failure than children with CML receiving imatinib as frontline therapy: a retrospective multicentre study (Dou X et al. Ann Hematol, June 2021)
Adolescents experienced more treatment failure than children with CML receiving imatinib as frontline therapy: a retrospective multicentre study
Dou X et al. Ann Hematol, June 2021 (epub ahead of print)
